We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

ROCHE DIAGNOSTICS CORP

Roche Diagnostics Corporation is the North American headquarters of Roche Diagnostics, a global leader in diagnostics... read more Featured Products: More products

Download Mobile App




Early Serum Creatinine Predicts Post-Surgery AKI

By LabMedica International staff writers
Posted on 05 Apr 2017
Print article
Image: The Combur 10 urinalysis test strips (Photo courtesy of Roche).
Image: The Combur 10 urinalysis test strips (Photo courtesy of Roche).
Acute Kidney Injury (AKI) is a common and serious complication of cardiac surgery. Mild AKI occurs in nearly one in five patients undergoing cardiac surgery and is associated with a 19-fold increase in short-term mortality.

It is important to identify patients who are at risk of developing AKI post cardiac surgery as historically and again recently, it has been shown that early nephrology referral for patients who develop AKI results in improved outcomes.

Scientists at the Monash Medical Centre and their colleagues prospectively studied 196 consecutive patients undergoing elective (on-pump) cardiac surgery. All patients undergoing on pump cardiac surgery had urinalysis for proteinuria and serum urea and creatinine determined within one month prior to surgery. The study population was predominantly male (73.5%) with the median age of enrolled participants being 70.8 years (range 30–91).

Serum urea and creatinine were subsequently collected immediately upon arrival to intensive care unit (ICU), within two hours of surgery completion, daily for 48 hours, and prior to discharge. Urinalysis was performed using Roche Combur 10 Test Strips and proteinuria was graded according to severity ranging from no detectable protein at 0 to a maximum score of 3 as annotated on the urinalysis kit. Subjects were classified as having proteinuria if the test strip score was 1 or higher.

The scientists reported that the mean pre-operative creatinine was 86 μmmol/L (range 40–246; SD 27.0) with a mean eGFR of 75.63 mL/min/1.73 m2 (range 21.59–118.8 ± 18.75) and 19% of the cohort had diabetes and 40 (20.4%) patients developed AKI postoperatively. Hypertension (OR 2.64), diabetes (OR 2.25), proteinuria (OR 2.48), and a lower baseline eGFR (OR 0.74) were associated with AKI in univariate analysis. A fall of greater than 15% from baseline in the early post-operative serum creatinine was protective for the development of AKI (OR = 0.34). On its own, the change in early post-operative serum creatinine was poorly predictive for AKI.

The authors concluded that a rise of greater than 15% in serum creatinine (sCr) over baseline, taken within two hours of arrival to ICU, equated to an odds ratio of seven for the development of AKI. This is important as sCr is an inexpensive, readily available test and measurements of early sCr could easily be incorporated into clinical practice, even in resource poor settings. They suggest that patients who demonstrate an increase in early sCr should be referred to a nephrologist in a timely manner. This would enable early interventions and potentially improve outcomes. The study was published on March 16, 2017, in the journal BMC Nephrology.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.